ARECOR THERAPEUTICS PLC
Biopharmaceutical company enhancing medicines with its proprietary formulation technology.
AREC | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMWLM973
- LEI:
- 98450093D12I3A8DDD58
- Country:
- United Kingdom
- Address:
- Chesterford Research Park, CB10 1XL Saffron Walden
- Website:
- https://arecor.com/
- Sector:
- Manufacturing
Description
Arecor Therapeutics plc is a clinical-stage biopharmaceutical company focused on developing enhanced therapeutic medicines. The company utilizes its proprietary Arestat® technology platform, a formulation science designed to improve the properties of proteins and peptides, enabling superior drug product profiles. Arecor's business model involves two approaches: developing an internal portfolio of proprietary products and partnering with pharmaceutical and medtech companies to enhance their therapeutic offerings. The company's in-house development pipeline is primarily focused on advancing treatments for diabetes and other cardiometabolic diseases, including next-generation insulin candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-01-20 08:00 |
ARECOR COMMENCES US PHASE I TRIAL OF AT247
|
English | 13.7 KB | ||
| 2021-12-21 08:00 |
Arecor Provides Update on Agreement with Hikma
|
English | 14.4 KB | ||
| 2021-12-14 08:00 |
Arecor Collaborates with Global Technology Leader
|
English | 12.9 KB | ||
| 2021-11-25 08:00 |
Grant of Options, PDMR Dealing
|
English | 25.1 KB | ||
| 2021-11-11 08:00 |
Holdings in Company
|
English | 47.6 KB | ||
| 2021-11-11 08:00 |
Arecor Granted Key Canadian Patent
|
English | 15.0 KB | ||
| 2021-11-01 08:00 |
Arecor announces formulation study collaboration
|
English | 12.8 KB | ||
| 2021-10-25 17:25 |
Exercise of options, PDMR, Total Voting Rights
|
English | 36.7 KB | ||
| 2021-10-11 10:18 |
Arecor’s Polysaccharide Vaccine Patent Upheld
|
English | 15.7 KB | ||
| 2021-09-23 08:00 |
INTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2021
|
English | 207.3 KB | ||
| 2021-09-22 17:41 |
Second Price Monitoring Extn
|
English | 2.8 KB | ||
| 2021-09-22 17:36 |
Price Monitoring Extension
|
English | 2.8 KB | ||
| 2021-09-22 15:06 |
Second Price Monitoring Extn
|
English | 2.8 KB | ||
| 2021-09-22 15:00 |
Price Monitoring Extension
|
English | 2.8 KB | ||
| 2021-09-22 12:06 |
Second Price Monitoring Extn
|
English | 2.8 KB |
Automate Your Workflow. Get a real-time feed of all ARECOR THERAPEUTICS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ARECOR THERAPEUTICS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ARECOR THERAPEUTICS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
